AIM: In metastatic prostate cancer patients PSMA targeting radioligands have gained significant impact as theranostic probes. In this study a correlation between total tumor volume (TTV) and measured kidney dose as well as salivary glands (SG) uptake in 177Lu-PSMA-617 therapy was evaluated. METHODS: Eleven consecutive prostate cancer patients receiving a first cylcle of 177Lu-PSMA-617 (administered activity of approximately 6GBq) were included. The 68Ga-PSMA-11 PET/CT scan previous to therapy was used to determine TTV and SG uptake (glandulae submandibularis) employing PMOD version 3.403 with different 68Ga-PSMA-11 thresholds based on the standardized uptake value (SUV).The kidney dose was estimated with the software ULMDOS using planar whole-body scintigrams. RESULTS: Kidney dose and SG uptake was inversely correlated to TTV, indicating high kidney dose and high SG uptake in case of low tumor load and low kidney dose and low SG uptake in case of high tumor load. CONCLUSION: Our data support the hypothesis that in 177Lu-PSMA-617 therapy an individualized treatment activity based on total tumor volume could be beneficiary. Schattauer GmbH.
AIM: In metastatic prostate cancerpatientsPSMA targeting radioligands have gained significant impact as theranostic probes. In this study a correlation between total tumor volume (TTV) and measured kidney dose as well as salivary glands (SG) uptake in 177Lu-PSMA-617 therapy was evaluated. METHODS: Eleven consecutive prostate cancerpatients receiving a first cylcle of 177Lu-PSMA-617 (administered activity of approximately 6GBq) were included. The 68Ga-PSMA-11 PET/CT scan previous to therapy was used to determine TTV and SG uptake (glandulae submandibularis) employing PMOD version 3.403 with different 68Ga-PSMA-11 thresholds based on the standardized uptake value (SUV).The kidney dose was estimated with the software ULMDOS using planar whole-body scintigrams. RESULTS: Kidney dose and SG uptake was inversely correlated to TTV, indicating high kidney dose and high SG uptake in case of low tumor load and low kidney dose and low SG uptake in case of high tumor load. CONCLUSION: Our data support the hypothesis that in 177Lu-PSMA-617 therapy an individualized treatment activity based on total tumor volume could be beneficiary. Schattauer GmbH.
Authors: Alexander Heinzel; Dima Boghos; Felix M Mottaghy; Florian Gaertner; Markus Essler; Dirk von Mallek; Hojjat Ahmadzadehfar Journal: Eur J Nucl Med Mol Imaging Date: 2019-01-29 Impact factor: 9.236
Authors: Hendrik Rathke; Clemens Kratochwil; Ralph Hohenberger; Frederik Lars Giesel; Frank Bruchertseifer; Paul Flechsig; Alfred Morgenstern; Matti Hein; Peter Plinkert; Uwe Haberkorn; Olcay Cem Bulut Journal: Eur J Nucl Med Mol Imaging Date: 2018-08-27 Impact factor: 9.236
Authors: Heike Endepols; Agnieszka Morgenroth; Boris D Zlatopolskiy; Philipp Krapf; Johannes Zischler; Raphael Richarz; Sergio Muñoz Vásquez; Bernd Neumaier; Felix M Mottaghy Journal: BMC Cancer Date: 2019-06-26 Impact factor: 4.430
Authors: Agnieszka Morgenroth; Ebru Tinkir; Andreas T J Vogg; Ramya Ambur Sankaranarayanan; Fatima Baazaoui; Felix M Mottaghy Journal: Breast Cancer Res Date: 2019-10-22 Impact factor: 6.466
Authors: Silvano Gnesin; Joachim Müller; Irene A Burger; Alexander Meisel; Marco Siano; Martin Früh; Matthias Choschzick; Cristina Müller; Roger Schibli; Simon M Ametamey; Philipp A Kaufmann; Valerie Treyer; John O Prior; Niklaus Schaefer Journal: EJNMMI Res Date: 2020-04-08 Impact factor: 3.138
Authors: Clemens Kratochwil; Leonidas Apostolidis; Hendrik Rathke; Christos Apostolidis; Felix Bicu; Frank Bruchertseifer; Peter L Choyke; Uwe Haberkorn; Frederik L Giesel; Alfred Morgenstern Journal: Eur J Nucl Med Mol Imaging Date: 2021-08-26 Impact factor: 9.236
Authors: Ashley A Stegelmeier; Lisa A Santry; Matthew M Guilleman; Kathy Matuszewska; Jessica A Minott; Jacob G E Yates; Brenna A Y Stevens; Sylvia P Thomas; Sierra Vanderkamp; Kiersten Hanada; Yanlong Pei; Amira D Rghei; Jacob P van Vloten; Madison Pereira; Brad Thompson; Pierre P Major; James J Petrik; Byram W Bridle; Sarah K Wootton Journal: Biomedicines Date: 2022-02-02